This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Biontech Rna Pharmaceuticals Gmbh, Tron—translationale Onkologie an Der Universitátsmedizin Der Johannes Gutenberg—universität Mainz Gemeinnützige Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 19 
1 out of 25 Years Active: 2026
Title: Lina Hilscher: RNA-Based Cancer Immunotherapy Innovation.
Introduction
Lina Hilscher is an inventor associated with Dortmund, Germany. Her patent work concerns RNA-based approaches designed to support immune responses against cancer.
Latest Patents
Hilscher is named on 1 patent: “Compositions Comprising Non-Immunogenic RNA Encoding Immunogenic Epitopes and Interferon Alpha.” The invention describes compositions combining RNA that encodes immunogenic epitopes with interferon alpha.
Career Highlights
Hilscher has been associated with BioNTech RNA Pharmaceuticals GmbH and TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH. These organizations work in biotechnology and translational oncology, fields relevant to the development of cancer immunotherapies.
Collaborations
Her named coworkers include Ugur Sahin and Lena Mareen Kranz. The patent reflects collaborative research into RNA-based compositions and immune-targeting strategies.
Conclusion
Lina Hilscher’s recorded patent activity centers on an RNA-based cancer immunotherapy composition, connecting her work with biotechnology and translational oncology research in Germany.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile